- Home
- SQFT vs ALBT Comparison
SQFT vs ALBT Comparison
Compare SQFT & ALBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SQFT | ALBT |
|---|---|---|
| Founded | 1999 | 2014 |
| Country | United States | United States |
| Employees | 15 | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5M | 3.3M |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | SQFT | ALBT |
|---|---|---|
| Price | $3.76 | $0.40 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 1.3M | 557.9K |
| Earning Date | 05-13-2026 | 08-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 33.18 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.59 | $0.34 |
| 52 Week High | $23.00 | $4.74 |
Technical Indicators
Market Signals| Indicator | SQFT | ALBT |
|---|---|---|
| Relative Strength Index (RSI) | 55.81 | 39.35 |
| Support Level | $3.07 | $0.34 |
| Resistance Level | $4.22 | $0.51 |
| Average True Range (ATR) | 0.36 | 0.05 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 55.96 | 34.46 |
Price Performance
Historical ComparisonAbout SQFT Presidio Property Trust Inc.
Presidio Property Trust Inc is an internally managed, diversified REIT with holdings in model home properties which are triple-net leased to homebuilders, office, industrial, and retail properties. Presidio's model homes are leased to homebuilders located in Arizona, Illinois, Texas, Wisconsin, and Florida. The office, industrial and retail properties are located in Colorado, with properties also located in Maryland, North Dakota, Texas, and Southern California.
About ALBT Avalon GloboCare Corp.
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment, which is the key revenue driver, and the laboratory testing services segment. The company focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.